8 terminated. 8 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 3 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
Follow Clostridium Difficile Infection: new trials by email Literature Review of Clostridium Difficile Infection trials Research Report on Clostridium Difficile Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplant for Primary CDI Fecal microbiota transplant G3 capsules, Oral Vancomycin alone - Clostridium Difficile Infection | Phase 1 / Phase 2 | Terminated | Boston Medical Center | 5 | 2019-08-23 | 2021-12-15 |
| Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) Fecal Microbiota Therapy (FMT), Placebo - Clostridium Difficile Infection | Phase 2 / Phase 3 | Terminated | VA Office of Research and Development | 153 | 2018-11-15 | 2024-04-11 |
| Treatment for Clostridium-difficile Infection With IMM529 IMM-529, Placebo - Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence | Phase 1 / Phase 2 | Terminated | Immuron Ltd. | 9 | 2017-09-01 | 2019-12-26 |
| Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) Cadazolid, Vancomycin capsule, Vancomycin solution - Clostridium Difficile Infection | Phase 2 / Phase 3 | Terminated | Actelion | 1 | 2017-04-14 | 2025-07-08 |
| Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir kefir - Clostridium Difficile Infection, Diarrhea | Phase 2 | Terminated | St. Luke's Hospital of Duluth | 2 | 2015-11-01 | 2022-05-19 |
| Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection Alanyl-glutamine - Clostridium Difficile Infection | Phase 2 | Terminated | University of Virginia | 7 | 2015-04-01 | 2022-06-07 |
| IMT for Primary Clostridium Difficile Infection Intestinal microbiota therapy, Metronidazole - Clostridium Difficile Infection | Phase 2 / Phase 3 | Terminated | Oslo University Hospital | 21 | 2015-02-22 | 2020-09-22 |
| FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI FMT, Antimicrobials - Clostridium Difficile Infection | Phase 2 | Terminated | Endeavor Health | 6 | 2015-01-01 | 2023-03-03 |
Clostridium Infections (8) · Diarrhea (3) · Communicable Diseases (1) · Dysbiosis (1)
Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Gram-Positive Bacterial Infections (8) · Infections (8) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Signs and Symptoms, Digestive (3) · Pathologic Processes (2) · Disease Attributes (1)
Vancomycin (2) · Anti-Infective Agents (1) · Fecal Microbiota Transplantation (1) · Kefir (1) · Metronidazole (1) · alanylglutamine (1) · cadazolid (1)
Actelion (1) · Boston Medical Center (1) · Endeavor Health (1) · Immuron Ltd. (1) · Oslo University Hospital (1) · St. Luke's Hospital of Duluth (1) · University of Virginia (1) · VA Office of Research and Development (1)
United States (5) · Belgium (1) · Canada (1) · Czechia (1) · Hungary (1) · Israel (1) · Italy (1) · Norway (1) · Poland (1) · Romania (1) · Spain (1)
Aasma Shaukat, MD MPH (1) · Becky Smith, MD (1) · Cirle A. Warren, M.D. (1) · Dimitri M Drekonja, MD (1) · Jennifer Grant, MD (1) · Jerry Kanellos (1) · Johan S Bakken, M.D., Ph.D. (1) · Kjetil K Garborg, MD, Ph.d. (1) · Michael Bretthauer, Ph.d. (1) · Neta Tobis (1) · Tamar Barlam, MD MSC (1)
2015 (1)